今天是:2021-01-18 星期一

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 开发卫生政策和系统研究的国家变革故事(中国案例)
下载XML文档

注册号:

Registration number:

ChiCTR2000040031 

最近更新日期:

Date of Last Refreshed on:

2021-01-03 

注册时间:

Date of Registration:

2020-11-18 

注册号状态:

预注册  

Registration Status:

Prospective registration  

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 开发卫生政策和系统研究的国家变革故事(中国案例) 

Public title:

Research impact assessment: developing national stories of change for health policy and systems research (the China case) 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

开发卫生政策和系统研究的国家变革故事(中国案例) 

Scientific title:

Developing national stories of change for health policy and systems research (the China case) 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

何欢 

研究负责人:

阿德南·海德尔 

Applicant:

Huan He 

Study leader:

Adnan Hyder 

申请注册联系人电话:

Applicant telephone:

+86 28 87092287 

研究负责人电话:

Study leader's telephone:

1-202-994-0383 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

hehuan@swufe.edu.cn 

研究负责人电子邮件:

Study leader's E-mail:

hydera1@gwu.edu 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

四川成都光华村街55号 

研究负责人通讯地址:

美国华盛顿特区,西北华盛顿区,新罕布什尔大道950号 

Applicant address:

55, Guanghuacun Street, Qingyang District, Chengdu, Sichuan 

Study leader's address:

950 New Hampshire Ave, NW Washington, DC 20052, USA 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

西南财经大学公共管理学院 

Applicant's institution:

School of Public Administration,Southwestern University of Finance and Economics 

是否获伦理委员会批准:

否 

Approved by ethic committee:

NO 

伦理委员会批件文号:

Approved No. of ethic committee:

 

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

 

Name of the ethic committee:

 

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 

伦理委员会联系人:

 

Contact Name of the ethic committee:

 

伦理委员会联系地址:

 

Contact Address of the ethic committee:

 

伦理委员会联系人电话:

Contact phone of the ethic committee:

 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

 

研究实施负责(组长)单位:

乔治华盛顿大学米尔肯研究所公共卫生学院全球卫生系 

Primary sponsor:

Department of Global Health, Milken Institute School of Public Health, the George Washington University 

研究实施负责(组长)单位地址:

美国华盛顿特区,西北华盛顿区,新罕布什尔大道950号 

Primary sponsor's address:

950 New Hampshire Ave, NW Washington, DC 20052, USA 

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

成都

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

西南财经大学公共管理学院

具体地址:

光华村街55号

Institution
hospital:

School of Public Administration at Southwestern university of finance and economics

Address:

55 Guanghuacun Street

经费或物资来源:

世界卫生组织卫生政策和系统研究联盟 

Source(s) of funding:

WHO's Alliance for Health Policy and Systems Research 

研究疾病:

不适用 

Target disease:

N/A 

研究疾病代码:

 

Target disease code:

 

研究类型:

卫生服务研究 

Study type:

Health Services Research 

研究所处阶段:

其它 

Study phase:

N/A 

研究目的:

评估卫生政策和系统联盟项目在加强能力,提高研究生产力,推进卫生政策和实践,改善中国卫生系统的影响和贡献。 

Objectives of Study:

To assess the impact and contributions of the Alliance for Health Policy and Systems Research (the Alliance) projects in strengthening capacity, increasing research productivity, advancing health policy and practice, and improve health systems in China 

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

横断面 

Study design:

Cross-sectional 

纳入标准:

(1)过去 10 年中获得卫生政策和系统联盟项目资助的卫生政策和系统研究人员,或 (2)参与国家和国家/或国家以下各级卫生政策或项目制定和/或执行的决策者,并在过去2或5年以来在从证据到政策的转化过程中和以上研究人员在其受资助研究领域有互动。 

Inclusion criteria

1. Health policy & systems researchers that have been recipients of HPSR grants from the Alliance during the last 10 years 2. Decision makers that have been involved in health policy or program formulation and/or implementation at the national and/or subnational levels, in areas related to Alliance-funded HPSR in China and that have interacted with the researcher informants in the last 2 or 5 years in processes of evidence to policy or program translation. 

排除标准:

(1)无法获取联系信息的研究项目人员 (2)未被以上研究人员按照互动标准进行提名的卫生政策或项目制定和/或执行的决策者 

Exclusion criteria:

1. Recipients of HPSR grants without contact information; 2. Decision makers that are not identified by the above researchers according to the inclusion criteria. 

研究实施时间:

Study execute time:

From2020-11-15To 2021-01-31 

征募观察对象时间:

Recruiting time:

From2020-11-15To 2020-12-31 

干预措施:

Interventions:

组别:

案例研究,无分组

样本量:

15

Group:

Case series

Sample size:

干预措施:

无干预

干预措施代码:

Intervention:

no intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国 

省(直辖市):

四川 

市(区县):

 

Country:

China 

Province:

Sichuan 

City:

 

单位(医院):

线上虚拟 

单位级别:

 

Institution
hospital:

virtual  

Level of the institution:

 

测量指标:

Outcomes:

指标中文名:

研究结果的发布

指标类型:

主要指标 

Outcome:

Research results disseminated

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

培训过的卫生政策与系统研究利益相关者

指标类型:

主要指标 

Outcome:

Trained HPSR stakeholders

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

资助项目产生的相关证据

指标类型:

主要指标 

Outcome:

Grant-related evidence

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

研究者-决策者的合作参与

指标类型:

主要指标 

Outcome:

Researcher - Decision maker engagement

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

研究者与决策者在工作重点上的一致性

指标类型:

主要指标 

Outcome:

Alignment between researchers and decision makers priorities

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

社交与沟通

指标类型:

主要指标 

Outcome:

Networking and communication

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

能力提升

指标类型:

主要指标 

Outcome:

Capacity gains

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

将证据转化为卫生政策

指标类型:

主要指标 

Outcome:

Translation of evidence into health policy

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

指标中文名:

卫生系统的收益

指标类型:

主要指标 

Outcome:

Health systems benefits

Type:

Primary indicator 

测量时间点:

测量方法:

访谈

Measure time point of outcome:

Measure method:

interview

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不涉及到随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

No

盲法:

N/A

Blinding:

N/A

原始数据公开时间:

The time of sharing IPD:

试验完成后6个月内公开/Within six months after the trial complete

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

详情请联系研究负责人

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Correspondence communication

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

MS Word和Nvivo12

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

MS Word and Nvivo12

数据管理委员会:

Data Managemen Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-11-18
返回列表